Clinical trial
Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin…
NCT00166881 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00166881 |
|---|---|
| Title | Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin |
| Official title | Phase II Trial of Consolidation or Salvage Chemotherapy by Using Weekly Docetaxel/Irinotecan After Cisplatin Plus Weekly 24-Hour Infusion of High-dose 5-Fluorouracil/Leucovorin for Non-resectable Gastric Cancers |
| Acronym | P-HDFL-DI |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | Far Eastern Memorial Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel-Irinotecan |
| Enrollment | 29 |
| Start date | Jun 1, 2000 |
| Primary completion | Dec 1, 2010 |
| Completion | Jun 1, 2011 |
| First posted | Sep 14, 2005 |
| Last update posted | Jul 8, 2013 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: